CEFPOZAL-CV 325

Cefpozal-CV 325 contains Cefpodoxime, a third-generation cephalosporin antibiotic, and Potassium Clavulanate, a beta-lactamase inhibitor. The combination enhances antibacterial efficacy against beta-lactamase-producing bacteria. It is used in the treatment of respiratory tract infections, urinary tract infections, skin infections, and certain ENT infections.